Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hiroto Inaba

Showing results (151-160 of 214) with videos related to

Pageof 22
Sort By:
Blood|April 21, 2012
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemiaWing Leung, Ching-Hon Pui, Elaine Coustan-Smith, et al.
British Journal of Haematology|August 29, 2014
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapySeth E Karol, Elaine Coustan-Smith, Xueyuan Cao, et al.
Haematologica|February 12, 2026
Body mass index during and early after therapy for pediatric acute lymphoblastic leukemia is associated with obesity in survivorsKunanya Suwannaying, Grace C Zhou, Nawachai Lertvivatpong, et al.
Pharmacogenetics and Genomics|June 20, 2017
Genetics of pleiotropic effects of dexamethasoneLaura B Ramsey, Stan Pounds, Cheng Cheng, et al.
Clinical and Translational Science|July 28, 2019
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AMLDaelynn R Buelow, Stanley B Pounds, Yong-Dong Wang, et al.
The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, et al.
Cancer|August 19, 2020
Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemiaSeth E Karol, Todd M Cooper, Paul E Mead, et al.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Pageof 22

Showing results (151-160 of 214) with videos related to

Sort By:
Pageof 22
Blood|April 21, 2012
Detectable minimal residual disease before hematopoietic cell transplantation is prognostic but does not preclude cure for children with very-high-risk leukemiaWing Leung, Ching-Hon Pui, Elaine Coustan-Smith, et al.
British Journal of Haematology|August 29, 2014
Prognostic factors in children with acute myeloid leukaemia and excellent response to remission induction therapySeth E Karol, Elaine Coustan-Smith, Xueyuan Cao, et al.
Haematologica|February 12, 2026
Body mass index during and early after therapy for pediatric acute lymphoblastic leukemia is associated with obesity in survivorsKunanya Suwannaying, Grace C Zhou, Nawachai Lertvivatpong, et al.
Pharmacogenetics and Genomics|June 20, 2017
Genetics of pleiotropic effects of dexamethasoneLaura B Ramsey, Stan Pounds, Cheng Cheng, et al.
Clinical and Translational Science|July 28, 2019
Uncovering the Genomic Landscape in Newly Diagnosed and Relapsed Pediatric Cytogenetically Normal FLT3-ITD AMLDaelynn R Buelow, Stanley B Pounds, Yong-Dong Wang, et al.
The Lancet. Oncology|May 11, 2010
Minimal residual disease-directed therapy for childhood acute myeloid leukaemia: results of the AML02 multicentre trialJeffrey E Rubnitz, Hiroto Inaba, Gary Dahl, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|October 29, 2019
Improved CNS Control of Childhood Acute Lymphoblastic Leukemia Without Cranial Irradiation: St Jude Total Therapy Study 16Sima Jeha, Deqing Pei, John Choi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 12, 2012
Comparative analysis of different approaches to measure treatment response in acute myeloid leukemiaHiroto Inaba, Elaine Coustan-Smith, Xueyuan Cao, et al.
Cancer|August 19, 2020
Safety, pharmacokinetics, and pharmacodynamics of panobinostat in children, adolescents, and young adults with relapsed acute myeloid leukemiaSeth E Karol, Todd M Cooper, Paul E Mead, et al.
Pediatric Blood & Cancer|October 16, 2019
Asparaginase formulation impacts hypertriglyceridemia during therapy for acute lymphoblastic leukemiaEmily R Finch, Colton A Smith, Wenjian Yang, et al.
Pageof 22